Read + Share
Amedeo Smart
Independent Medical Education
Matono T, Tada T, Kumada T, Hiraoka A, et al. Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab-Treated HCC. J Gastroenterol Hepatol 2025;40:949-959.PMID: 39844393
Email
LinkedIn
Privacy Policy